JYAMS PET Research & Development Limited

Quick facts

Phase 3 pipeline

• [18F]-APN-1607
  This drug is a radioligand used for positron emission tomography (PET) imaging.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• JYAMS PET Research & Development Limited portfolio CI brief
• JYAMS PET Research & Development Limited pipeline updates RSS